Vault-13

Foresite Capital Management VI LLC

WEST HOLLYWOOD, CA · CIK 2013341 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$642.6m reported value +39.6% vs Q1 2026
23positions
81.5%in top 10
8 new 6 added 1 reduced 2 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CG ONCOLOGY INC COM CGON CGON 2,369,574 $168.4m26.20% 26.20% AddedShares held: Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 2.2m, Q2 2026 2.4m +148.1k +148,100 6.7%
2 ALUMIS INC COM ALMS ALMS 4,247,670 $119.5m18.60% 18.60% UnchangedShares held: Q3 2025 4.2m, Q4 2025 4.2m, Q1 2026 4.2m, Q2 2026 4.2m
3 SEAPORT THERAPEUTICS INC COMMON STOCK SPTX SPTX 1,779,521 $38.7m6.02% 6.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.8m
4 DENALI THERAPEUTICS INC COM DNLI DNLI 1,396,771 $35.9m5.59% 5.59% AddedShares held: Q3 2025 1.0m, Q4 2025 1.0m, Q1 2026 1.2m, Q2 2026 1.4m +186.8k +186,800 15.4%
5 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 879,713 $32.7m5.09% 5.09% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 315.9k, Q2 2026 879.7k +563.8k +563,800 178.5%
6 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 785,000 $29.1m4.53% 4.53% AddedShares held: Q3 2025 0, Q4 2025 530.0k, Q1 2026 525.0k, Q2 2026 785.0k +260.0k +260,000 49.5%
7 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 1,831,233 $27.4m4.26% 4.26% UnchangedShares held: Q3 2025 1.7m, Q4 2025 1.4m, Q1 2026 1.8m, Q2 2026 1.8m
8 PARABILIS MEDICINES INC COM PBLS PBLS 999,044 $27.3m4.26% 4.26% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 999.0k
9 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 940,493 $25.3m3.93% 3.93% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 315.5k, Q2 2026 940.5k +625.0k +625,001 198.1%
10 JADE BIOSCIENCES INC COM NEW JBIO JBIO 886,667 $19.7m3.07% 3.07% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 320.0k, Q2 2026 886.7k +566.7k +566,667 177.1%
11 HINGE HEALTH INC CL A HNGE HNGE 220,400 $18.3m2.85% 2.85% UnchangedShares held: Q3 2025 135.0k, Q4 2025 135.0k, Q1 2026 220.4k, Q2 2026 220.4k
12 KYMERA THERAPEUTICS INC COM KYMR KYMR 146,332 $16.8m2.61% 2.61% UnchangedShares held: Q3 2025 146.3k, Q4 2025 146.3k, Q1 2026 146.3k, Q2 2026 146.3k
13 ATAIBECKLEY INC COM SHS ATAI ATAI 2,750,000 $14.5m2.26% 2.26% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.8m, Q2 2026 2.8m
14 VERASTEM INC COM NEW VSTM VSTM 3,146,631 $12.0m1.87% 1.87% UnchangedShares held: Q3 2025 2.6m, Q4 2025 3.1m, Q1 2026 3.1m, Q2 2026 3.1m
15 BEAM THERAPEUTICS INC COM BEAM BEAM 330,000 $11.3m1.76% 1.76% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 330.0k
16 MINERVA NEUROSCIENCES INC COM NEW NERV NERV 1,985,584 $11.0m1.71% 1.71% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.0m, Q2 2026 2.0m -1.0k -1,016 -0.1%
17 ARRIVENT BIOPHARMA INC COM AVBP AVBP 301,341 $10.5m1.63% 1.63% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 301.3k
18 AURA BIOSCIENCES INC COM AURA AURA 1,333,334 $9.5m1.47% 1.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.3m
19 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 212,010 $7.9m1.23% 1.23% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 212.0k, Q2 2026 212.0k
20 RESEARCH ALLIANCE CORP III ORD SHS CL A RACC RACC 300,000 $3.2m0.50% 0.50% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 300.0k
21 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 450,000 $2.7m0.41% 0.41% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 450.0k, Q2 2026 450.0k
22 KAILERA THERAPEUTICS INC COMMON STOCK KLRA KLRA 37,500 $826.1k0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 37.5k
23 DISC MEDICINE INC COM IRON IRON 970 $70.9k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 970

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
CENTESSA PHARMACEUTICALS PLC 1,364,019 $54.2m1.4m shares
ONKURE THERAPEUTICS INC OKUR OKUR 1,445,783 $6.0m1.4m shares